Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | DSP-7888 |
| Trade Name | |
| Synonyms | Ombipepimut-s|DSP 7888|DSP7888 |
| Drug Descriptions |
Ombipepimut-s (DSP-7888) is a peptide vaccine that potentially induces anti-tumor immune response against tumor cells with WT1 over expression (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C121957 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + DSP-7888 | Atezolizumab DSP-7888 | 0 | 1 |
| Bevacizumab + DSP-7888 | Bevacizumab DSP-7888 | 0 | 1 |
| DSP-7888 | DSP-7888 | 0 | 1 |
| DSP-7888 + Nivolumab | DSP-7888 Nivolumab | 0 | 1 |